Business new tamfitronics
PUBLISHED ONAlso can just 13, 2024 8:30 PM
Nyxoah to Launch First Quarter 2024 Monetary Outcomes on Also can just 14, 2024
Mont-Saint-Guibert, Belgium – Also can just 13, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Firm”), a scientific technology company centered on the advance and commercialization of modern choices to treat Obstructive Sleep Apnea (OSA), on the present time introduced that the Firm will open financial outcomes for the first quarter 2024 on Tuesday, Also can just 14, 2024, after market close. Firm management will host a convention call to focus on financial outcomes that day beginning at 10:30pm CET / 4:30pm ET.
A webcast of the probability can be accessible via the Investor Relations net page of the Nyxoah net pages or via this hyperlink: Nyxoah’s Q1 2024 earnings call webcast. For those now not planning to acquire aside a requirement to a requirement management, the Firm recommends listening via the webcast.
Within the occasion you plot to acquire aside a requirement to a requirement, please exhaust the following hyperlink: Nyxoah’s Q1 2024 earnings call. After registering, an email can be despatched, including dial-in crucial aspects and a unfamiliar convention call access code required to enroll within the reside call. To catch certain you are connected earlier than the beginning of the probability, the Firm suggests registering a minimum of 10 minutes earlier than the open of the probability.
The archived webcast can be readily accessible for replay rapidly after the close of the probability.
About Nyxoah
Nyxoah is a scientific technology company centered on the advance and commercialization of modern choices to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the sector’s most popular sleep disordered respiratory condition that is associated with increased mortality probability and cardiovascular comorbidities. Nyxoah is pushed by the vision that OSA sufferers ought to revel in restful nights and feel enabled to reside their lifestyles to its fullest.
For more data, please visit http://www.nyxoah.com/.
Caution – CE marked since 2019. Investigational instrument within the United States. Restricted by U.S. federal regulation to investigational exhaust within the United States.
Forward-having a scrutinize statements
Sure statements, beliefs and opinions on this press open are forward-having a scrutinize, which judge the Firm’s or, as appropriate, the Firm administrators’ or managements’ fresh expectations referring to the Genio® system; planned and ongoing scientific experiences of the Genio® system; the prospective advantages of the Genio® system; Nyxoah’s targets with respect to the advance, regulatory pathway and skill exhaust of the Genio® system; the utility of scientific data in doubtlessly obtaining FDA approval of the Genio® system; and the Firm’s outcomes of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-having a scrutinize statements involve a series of risks, uncertainties, assumptions and assorted factors that will possibly well well also cause true outcomes or events to alter materially from those expressed or implied by the forward-having a scrutinize statements. These risks, uncertainties, assumptions and factors might well well also adversely affect the final consequence and financial outcomes of the plans and events described herein. Furthermore, these risks and uncertainties encompass, but are now not restricted to, the dangers and uncertainties situation forth within the “Possibility Components” part of the Firm’s Annual Document on Produce 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Payment (“SEC”) on March 20, 2024, and subsequent experiences that the Firm recordsdata with the SEC. A huge kind of things including, but now not restricted to, changes in demand, competition and technology, can cause true events, performance or outcomes to alter vastly from any anticipated pattern. Forward having a scrutinize statements contained on this press open referring to past trends or activities are now not guarantees of future performance and ought to now not be taken as a illustration that such trends or activities will continue in some unspecified time in the future. Besides, even if true outcomes or trends are in conserving with the forward-having a scrutinize statements contained on this press open, those outcomes or trends might well now not be indicative of outcomes or trends in future sessions. No representations and warranties are made as to the accuracy or equity of such forward-having a scrutinize statements. This implies that, the Firm expressly disclaims any obligation or project to open any updates or revisions to any forward-having a scrutinize statements on this press open as a outcomes of any switch in expectations or any switch in events, instances, assumptions or conditions on which these forward-having a scrutinize statements are basically based mostly, with the exception of if particularly required to maintain so by regulation or regulation. Neither the Firm nor its advisers or representatives nor any of its subsidiary undertakings or the kind of person’s officers or workers guarantees that the assumptions underlying such forward-having a scrutinize statements are free from errors nor does either earn any responsibility for the future accuracy of the forward-having a scrutinize statements contained on this press open or the particular incidence of the forecasted trends. You might now not build undue reliance on forward-having a scrutinize statements, which order simplest as of the date of this press open.
Contacts:
Nyxoah
David DeMartino, Chief Technique Officer
[email protected]
Fragment this article
This net pages is finest considered utilizing essentially the most stylish versions of net browsers.
